| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | Chief Medical Officer | Feb 20, 2021 | Option Exercise | $18.79 | 35,672 | 670,277 | 242,499 | Feb 23, 2021, 06:05 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | Chief Medical Officer | Nov 20, 2020 | Option Exercise | $17.21 | 4,639 | 79,837 | 278,171 | Nov 24, 2020, 06:16 PM | |
| AIMT | Aimmune Therapeutics, Inc. | HAUMANN BRETT K | Director | Oct 10, 2020 | Option Exercise | $34.50 | 6,250 | 215,625 | 0 | Oct 14, 2020, 04:15 PM | |
| AIMT | Aimmune Therapeutics, Inc. | HAUMANN BRETT K | Director | Oct 13, 2020 | Option Exercise | $34.50 | 13,313 | 459,299 | 0 | Oct 14, 2020, 04:15 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | Chief Medical Officer | Aug 20, 2020 | Option Exercise | $18.22 | 4,646 | 84,650 | 307,810 | Aug 24, 2020, 06:21 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | Chief Medical Officer | Aug 21, 2020 | Sale | $18.29 | 25,000 | 457,240 | 282,810 | Aug 24, 2020, 06:21 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2020 | Option Exercise | $26.67 | 4,212 | 112,334 | 312,456 | May 22, 2020, 06:06 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2020 | Option Exercise | $25.90 | 33,608 | 870,447 | 316,668 | Feb 24, 2020, 07:07 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2019 | Option Exercise | $17.60 | 2,692 | 47,379 | 231,276 | Nov 22, 2019, 06:20 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2019 | Option Exercise | $21.51 | 2,710 | 58,292 | 233,968 | Aug 22, 2019, 06:00 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2019 | Option Exercise | $19.84 | 2,705 | 53,667 | 236,678 | May 22, 2019, 06:05 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2019 | Option Exercise | $27.00 | 7,778 | 210,006 | 239,383 | Feb 22, 2019, 06:13 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2018 | Option Exercise | $24.79 | 7,368 | 182,653 | 134,911 | Nov 21, 2018, 05:43 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2018 | Option Exercise | $26.95 | 6,683 | 180,107 | 142,279 | Aug 22, 2018, 07:33 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2018 | Option Exercise | $24.31 | 26,991 | 656,151 | 148,962 | May 22, 2018, 07:01 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2018 | Option Exercise | $29.09 | 8,293 | 241,243 | 142,203 | Feb 22, 2018, 05:39 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2017 | Option Exercise | $28.58 | 7,846 | 224,239 | 141,496 | Nov 22, 2017, 04:37 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2017 | Option Exercise | $27.40 | 7,064 | 193,554 | 149,342 | Aug 22, 2017, 06:28 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2017 | Option Exercise | $36.83 | 7,065 | 260,204 | 156,406 | May 23, 2017, 07:59 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Mar 07, 2017 | Sale | $30.80 | 424 | 13,059 | 163,471 | Mar 08, 2017, 06:11 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Mar 06, 2017 | Sale | $31.52 | 13,576 | 427,916 | 163,895 | Mar 08, 2017, 06:11 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2017 | Option Exercise | $33.78 | 14,434 | 487,581 | 177,471 | Feb 22, 2017, 07:06 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2016 | Option Exercise | $31.96 | 5,388 | 172,200 | 182,905 | Nov 22, 2016, 06:02 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 25, 2016 | Sale | $27.99 | 4,491 | 125,703 | 188,293 | Aug 25, 2016, 07:34 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2016 | Option Exercise | $27.89 | 4,607 | 128,489 | 192,784 | Aug 23, 2016, 07:23 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 19, 2016 | Sale | $27.97 | 9,509 | 265,967 | 197,391 | Aug 23, 2016, 07:23 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2016 | Option Exercise | $20.55 | 4,608 | 94,694 | 206,900 | May 24, 2016, 07:59 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP, Clinical Development | Feb 20, 2016 | Option Exercise | $15.65 | 18,425 | 288,351 | 121,508 | Feb 23, 2016, 07:56 PM | |
| TBPH | Theravance Biopharma, Inc. | HAUMANN BRETT K | SVP, Clinical Development | Nov 20, 2015 | Option Exercise | $17.17 | 781 | 13,410 | 139,933 | Nov 24, 2015, 07:36 PM |
Menu